FDA orphan drug designation: treatment of beta-thalassemia
All entries for: Zydus Lifesciences Limited
November 4, 2025
Zydus Lifesciences Limited
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of beta-thalassemia